<DOC>
	<DOCNO>NCT00927836</DOCNO>
	<brief_summary>The purpose study assess efficacy AX200 ( filgrastim ) treatment acute ischemic stroke ass safety tolerability AX200 .</brief_summary>
	<brief_title>AXIS 2 : AX200 Treatment Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Major diagnosis acute ischemic stroke onset within 9 hour prior start study agent administration ischemic stroke MCA territory confirm MRI ( diffusion ) age ≥18 year ≤85 year lesion size DWI ≥15 ccm write informed consent Major prior current stroke : inability walk lead independent life life expectancy less equal 6 month stupor coma lacunar infarct evidence ICH malignant hypertension presence history active malignancy platelet count &lt; 100/nl randomization leukocyte count &gt; 20/nl randomization congenital neutropenia pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>